About
197.00DKK+0.20 +0.10%
Closed • Updated at 07:09 GMT+00:00Market Cap$2.41B
P/E Ratio13.11
Volume240.6K
Beta0.29
RSI56.75
Gross Margin47.05%
Bavarian Nordic A/s — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Bavarian Nordic Announces Interim Results for the First Three Months of 2026
May 11 2026
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
Apr 21 2026
Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S
Apr 20 2026
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Apr 16 2026
Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine
Recent Videos

LCC-beregninger hos Bavarian Nordic A/S fører til opgradering af filtre og store energibesparelser
May 13, 2025

BVNRY Bavarian Nordic A/S ADR Dividend History
Apr 14, 2025

Monkeypox Vaccine वैक्सीन Bavarian Nordic A/S को मिली WHO की मंजूरी News Public Health
Sep 16, 2024

BVNRY Stock - Bavarian Nordic ANALYSIS REVIEW - MPOX - Martyn Lucas Investor @MartynLucas
Aug 31, 2024
Community Chat
Ask AI
Try asking
Google Übersetzer